Etodolac-lidocaine Patch in Subjects Experiencing Acute Delayed Onset Muscle Soreness

Acute Delayed Onset Muscle Soreness (DOMS) Clinical Trial

Official title: A Randomized, Double-blind, Multiple-dose, Placebo-controlled Study to Evaluate the Efficacy and Safety of Etodolac-lidocaine Patch Applied Once Daily in Subjects Experiencing Acute Delayed Onset Muscle Soreness

Status Completed

Clinical Trial Summary

This study evaluate the efficacy and safety of Etodolac-lidocaine topical patch applied one time daily when compared with placebo in the treatment of acute Delayed Onset Muscle Soreness (DOMS) of the upper limbs.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Factorial Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Acute Delayed Onset Muscle Soreness (DOMS)
• Myalgia

• NCT number: NCT02695381
• Study type: Interventional
• Source: MEDRx USA, Inc.
• Status: Completed
• Phase: Phase 3
• Start date: March 2016
• Completion date: September 2016